|
|
|
MIRA INFORM REPORT
|
Report No. : |
483348 |
|
Report Date : |
02.01.2018 |
IDENTIFICATION DETAILS
|
Name : |
ZOETIS INDIA LIMITED (w.e.f. 23.04.2013) |
|
|
|
|
Formerly Known As
: |
PFIZER ANIMAL HEALTH INDIA LIMITED (w.e.f. 20.07.2010) VETNEX ANIMAL HEALTH LIMITED (w.e.f. 23.03.2009) VETNEX ANIMAL HEALTH PRIVATE LIMITED (w.e.f. 08.12.2008) ELEGANT E-SERVICES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
31, 3rd Floor, Kalpataru Synergy, Opposite Grand Hyatt,
Santacruz (East) Mumbai – 400055, Maharashtra |
|
Tel. No.: |
91-22-66513800 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2016 |
|
|
|
|
Date of
Incorporation : |
06.09.2007 |
|
|
|
|
Com. Reg. No.: |
11-203686 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 135.039 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U93000MH2007PLC203686 |
|
|
|
|
IEC No.: |
Not Divulged |
|
|
|
|
GSTIN/UIN: |
Not Divulged |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCE8269K |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in trading and manufacturing of animal
feeds and supplements. (Registered activity) |
|
|
|
|
No. of Employees
: |
Information denied by the management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January
2017)
|
MIRA’s Rating : |
B |
|
Credit Rating |
Explanation |
Rating Comments |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
Maximum Credit Limit : |
USD 2900000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company incorporated in the year 2007. It is
engaged in trading and manufacturing of animal feeds and supplements care. It is a wholly owned subsidiary of Zoetis Pharmaceutical
Research Private Limited, India and Zoetis Inc, USA is the ultimate holding company. Rating takes into consideration strong managerial and financial
support received to the company from its holding entity. Rating also takes into account of groups established track record of
business operations and market position. However, rating strength is partially offset due to continuous losses
incurred by the company. Trade relations are reported as fair. Business is active. Payments are
slow but correct, with slight caution initially. The company can be considered for business dealings at usual trade
terms and condition. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 28.12.2017
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DENIED BY
|
Name : |
Mr. Sameer |
|
Designation : |
Accounts Executive |
|
Contact No.: |
91-22-66513800 |
|
Date : |
28.12.2017 |
Management Non-Cooperative (91-1334-662120)
LOCATIONS
|
Registered Office : |
31, 3rd Floor, Kalpataru Synergy, Opposite Grand Hyatt, Santacruz
(East) Mumbai – 400055, Maharashtra |
|
Tel. No.: |
91-22-66513800 |
|
Fax No.: |
91-22-66716243 |
|
E-Mail : |
|
|
Website : |
DIRECTORS
AS ON 31.03.2017
|
Name : |
Mr. Ketan Ramesh Dhamanaskar |
||||||||||||
|
Designation : |
Managing Director |
||||||||||||
|
Address : |
A-1, 13th Floor, Bay View, Juhu Versova Link Road, Andheri (West), Mumbai 400053, Maharashtra, India |
||||||||||||
|
Date of Birth/Age : |
24.10.1967 |
||||||||||||
|
Qualification: |
M. Pharma., Master in Management Studies |
||||||||||||
|
Date of Appointment : |
29.09.2014 |
||||||||||||
|
DIN No.: |
02728160 |
||||||||||||
|
PAN No.: |
AAMPD9459J |
||||||||||||
|
|
|
||||||||||||
|
Name : |
Ms. Resha Mahabaleshwar Kantak |
||||||||||||
|
Designation : |
Whole Time Director |
||||||||||||
|
Address : |
6, Navneet CHS, 352, Dinanath Terrace Shimpoli, Near Bank of Baroda, Borivili (West), Mumbai – 400092, Maharashtra, India |
||||||||||||
|
Date of Birth/Age : |
22.08.1970 |
||||||||||||
|
Date of Appointment : |
01.11.2012 |
||||||||||||
|
PAN No.: |
AAZPK9705F |
||||||||||||
|
DIN No.: |
05247706 |
||||||||||||
|
|
|
||||||||||||
|
Name : |
Mr. Sanjiv Verma |
||||||||||||
|
Designation : |
Director |
||||||||||||
|
Address : |
S-87, First Floor, Panchsheel Park, New Delhi – 110017, India |
||||||||||||
|
Date of Birth/Age : |
28.08.1949 |
||||||||||||
|
Qualification: |
Bachelore in Chemical Engineering |
||||||||||||
|
Date of Appointment : |
19.11.2015 |
||||||||||||
|
DIN No.: |
00079498 |
||||||||||||
|
PAN No.: |
AAGPV6188G |
||||||||||||
|
Other Directorship:
|
|||||||||||||
|
|
|
||||||||||||
|
Name : |
Mr. Ravindranath Menon Kizhakkepat Bhaskaran |
||||||||||||
|
Designation : |
Director |
||||||||||||
|
Address : |
S-4, Spencer Court, 5 Spencer Road, Fraser Town, Bangalore – 560005, Karnataka, India |
||||||||||||
|
Date of Birth/Age : |
13.12.1955 |
||||||||||||
|
Qualification: |
Post Graduate in Management |
||||||||||||
|
Date of Appointment : |
19.11.2015 |
||||||||||||
|
DIN No.: |
02579565 |
||||||||||||
|
Other Directorship:
|
|||||||||||||
|
|
|
||||||||||||
|
Name : |
Mr. Siddharth Suresh Shah |
||||||||||||
|
Designation : |
Director |
||||||||||||
|
Address : |
204, Ariana, Raheja Acropolis - 2, Deonar Village Road, Deonar, Mumbai -400088, Maharashtra, India |
||||||||||||
|
Date of Birth/Age : |
09.08.1976 |
||||||||||||
|
Qualification: |
M. Pharm, MBA |
||||||||||||
|
Date of Appointment : |
30.09.2013 |
||||||||||||
|
DIN No.: |
06589168 |
||||||||||||
|
PAN No.: |
ALZPS7808L |
||||||||||||
KEY EXECUTIVES
|
Name : |
Ms. Resha Mahabaleshwar Kantak |
|
Designation : |
Chief Finance Officer |
|
Address : |
6, Navneet CHS, 352 Dinanath Terrace Shimpoli, Near Bank of Baroda, Borivili (West), Mumbai 400092, Maharashtra, India |
|
Date of Birth/Age : |
22.08.1970 |
|
Qualification: |
Cost Accounting Management |
|
Date of Appointment : |
29.09.2014 |
|
PAN No.: |
AAZPK9705F |
|
Name : |
Ms. Pooja Rajan |
|
Designation : |
Company Secretary |
|
Address : |
6, Narmada, Flat No. 9, Plot No. 24A, Sector 14, Vashi, Navi Mumbai – 400703, Maharashtra, India |
|
Date of Birth/Age : |
01.06.1985 |
|
Date of Appointment : |
04.02.2011 |
|
PAN No.: |
ALDPR4379G |
|
|
|
|
Name : |
Mr. Sameer |
|
Designation : |
Accounts Executive |
MAJOR SHAREHOLDERS
AS ON 31.03.2016
|
Names of Shareholders |
No. of Shares |
|
Zoetis Pharmaceutical Research Private Limited, India |
13503872 |
|
Shyam Kishan Chand Paliwal (Nominee of Zoetis Pharmaceutical Research
Private Limited) |
1 |
|
Ketan Ramesh Dhamanaskar (Nominee of Zoetis Pharmaceutical Research
Private Limited) |
1 |
|
Hari Prasad Yethirajyam (Nominee of Zoetis Pharmaceutical Research
Private Limited) |
1 |
|
Kavita Bhavnani (Nominee of Zoetis Pharmaceutical Research Private
Limited) |
1 |
|
Maneesh Jain (Nominee of Zoetis Pharmaceutical Research Private
Limited) |
1 |
|
Ramesh Mahabaleshwar Kantak (Nominee of Zoetis Pharmaceutical Research
Private Limited) |
1 |
|
Total |
13503878 |
Equity Share Break up (Percentage of Total Equity)
AS ON 09.09.2016
|
Category |
Percentage |
|
Promoters- Individual/Hindu Undivided Family- Indian |
0.00004443 |
|
Promoters- Body corporate |
99.99995557 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in trading and manufacturing of animal
feeds and supplements. (Registered activity) |
||||||
|
|
|
||||||
|
Products / Services
: |
|
||||||
|
|
|
||||||
|
Brand Names : |
Not Available |
||||||
|
|
|
||||||
|
Agencies Held : |
Not Available |
||||||
|
|
|
||||||
|
Exports : |
Not Divulged |
||||||
|
|
|
||||||
|
Imports : |
Not Divulged |
||||||
|
|
|
||||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Information denied by the management |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
|
Auditors : |
|
|
Name : |
B S R and Company LLP Chartered Accountants |
|
Address : |
5th Lodha Excelus, 1st Floor, Apollo Mills Compound, NM Joshi Marg, Mahalaxmi, Mumbai, Maharashtra, India |
|
PAN N Income-tax PAN of auditor or auditor's firm : |
AAAFB9852F |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Holding Company: |
[U24117MH1995FTC084206] |
|
|
|
|
Ultimate
Holding Company: |
|
|
|
|
|
Subsidiary company: |
|
|
|
|
|
Fellow subsidiary: |
|
CAPITAL STRUCTURE
AS ON 31.03.2016
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
568750000 |
Equity Shares |
INR 10/- each |
INR 5687.500 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
13503878 |
Equity Shares |
INR 10/- each |
INR 135.039 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
135.039 |
135.039 |
135.039 |
|
(b) Reserves and Surplus |
883.376 |
901.959 |
3269.864 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
(d) Minority interest |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
1018.415 |
1036.998 |
3404.903 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long-term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term provisions |
52.996 |
88.761 |
71.303 |
|
Total Non-current
Liabilities (3) |
52.996 |
88.761 |
71.303 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short-term
borrowings |
2526.400 |
2526.400 |
2262.000 |
|
(b) Trade
payables |
273.298 |
486.735 |
790.435 |
|
(c) Other
current liabilities |
1147.115 |
835.139 |
574.481 |
|
(d) Short-term
provisions |
95.702 |
103.218 |
58.158 |
|
Total Current
Liabilities (4) |
4042.515 |
3951.492 |
3685.074 |
|
|
|
|
|
|
TOTAL |
5113.926 |
5077.251 |
7161.280 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
83.561 |
420.671 |
387.476 |
|
(ii)
Intangible Assets |
1429.828 |
2086.888 |
0.000 |
|
(iii) Tangible assets
capital work-in-progress |
0.000 |
1.914 |
11.032 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.027 |
0.027 |
4725.459 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d)
Long-term loans and advances |
129.948 |
100.950 |
122.815 |
|
(e) Other
Non-current assets |
0.947 |
1.238 |
4.587 |
|
Total Non-Current
Assets |
1644.311 |
2611.688 |
5251.369 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
426.700 |
927.678 |
681.484 |
|
(c) Trade
receivables |
351.693 |
885.629 |
691.215 |
|
(d) Cash and
bank balances |
2609.142 |
500.969 |
133.807 |
|
(e)
Short-term loans and advances |
67.923 |
129.812 |
75.555 |
|
(f) Other
current assets |
14.157 |
21.475 |
327.850 |
|
Total
Current Assets |
3469.615 |
2465.563 |
1909.911 |
|
|
|
|
|
|
TOTAL |
5113.926 |
5077.251 |
7161.280 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
|
SALES |
|
|
|
|
|
Income |
2972.936 |
4233.197 |
3124.078 |
|
|
Other Income |
66.394 |
18.377 |
50.274 |
|
|
TOTAL |
3039.330 |
4251.574 |
3174.352 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
489.292 |
801.037 |
438.354 |
|
|
Purchases of
Stock-in-Trade |
1010.068 |
2198.021 |
1498.113 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
412.757 |
(240.741) |
(51.119) |
|
|
Employee benefit expense |
494.461 |
546.722 |
527.145 |
|
|
Expenditure on production, transportation
and Other expenditure pertaining to
exploration and production activities |
702.534 |
1001.879 |
0.000 |
|
|
Other expenses |
739.003 |
1077.602 |
868.319 |
|
|
Exceptional items |
(1025.784) |
0.000 |
0.000 |
|
|
TOTAL |
2822.331 |
5384.520 |
3280.812 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
216.999 |
(1132.946) |
(106.460) |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
256.067 |
259.007 |
240.518 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
(39.068) |
(1391.953) |
(346.978) |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
0.000 |
0.000 |
263.735 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE
TAX |
(39.068) |
(1391.953) |
(610.713) |
|
|
|
|
|
|
|
Less |
TAX |
0.000 |
0.000 |
97.144 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
(39.068) |
(1391.953) |
(707.857) |
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
200.501 |
171.606 |
NA |
|
|
TOTAL EARNINGS |
200.501 |
171.606 |
NA |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw Materials |
21.948 |
213.844 |
NA |
|
|
Components and spare
parts |
602.188 |
488.846 |
NA |
|
|
Capital Goods |
0.000 |
5.543 |
NA |
|
|
TOTAL IMPORTS |
624.136 |
708.233 |
NA |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
|
|
|
|
|
Basic |
(2.89) |
(172.82) |
(52.42) |
|
|
Diluted |
(2.89) |
(103.08) |
(52.42) |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
|
|
|
|
|
Cash generated from operations |
NA |
NA |
NA |
|
|
|
|
|
|
Net cash flows from (used in) operations |
449.262 |
137.779 |
16.053 |
|
|
|
|
|
|
Net cash flows from (used in) operating activities |
444.368 |
233.643 |
11.205 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
43.18 |
76.36 |
80.76 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
8.45 |
4.78 |
4.52 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
66.53 |
59.24 |
148.99 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
0.51 |
(1.22) |
(0.16) |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
0.14 |
(0.45) |
(0.27) |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.79 |
0.78 |
0.51 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
2.48 |
2.44 |
0.66 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
3.97 |
3.81 |
1.08 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
1.49 |
2.42 |
0.12 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
0.85 |
(4.37) |
(0.44) |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
(1.31) |
(32.88) |
(22.66) |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
(0.76) |
(27.42) |
(9.88) |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
(3.84) |
(134.23) |
(20.79) |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Ratio (Current
Assets / Current Liabilities) |
0.86 |
0.62 |
0.52 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
0.75 |
0.39 |
0.33 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.20 |
0.20 |
0.48 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
18.71 |
18.71 |
16.75 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
0.86 |
0.62 |
0.52 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Share Capital |
135.039 |
135.039 |
135.039 |
|
Reserves & Surplus |
3269.864 |
901.959 |
883.376 |
|
Money received against share
warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
3404.903 |
1036.998 |
1018.415 |
|
|
|
|
|
|
Long-term borrowings |
0.000 |
0.000 |
0.000 |
|
Short term borrowings |
2262.000 |
2526.400 |
2526.400 |
|
Total
borrowings |
2262.000 |
2526.400 |
2526.400 |
|
Debt/Equity
ratio |
0.664 |
2.436 |
2.481 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
3124.078 |
4233.197 |
2972.936 |
|
|
|
35.502 |
(29.771) |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
3124.078 |
4233.197 |
2972.936 |
|
Profit/ (Loss) |
(707.857) |
(1391.953) |
(39.068) |
|
|
(22.66
%) |
(32.88
%) |
(1.31
%) |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
No |
|
21 |
Banking facility details |
No |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
NOTE: Registered office of the company has been
shifted from 31 and 32, 3rd Floor, Kalpataru Synergy, Opposite Grand
Hyatt, Santacruz(East), Mumbai – 400055, Maharashtra,
India to the present address w.e.f. 01.02.2017
NATURE OF OPERATIONS
Subject was incorporated on 6 September 2007 as Elegant E Services Private Limited. The name of the Company was changed to Vetnex Animal Health Private Limited on 8 December 2008 and the Company was converted into a Public Company on 23 March 2009 and consequent to conversion into Public Limited Company the name was changed to Vetnex Animal Health Limited.
Pursuant to the Composite scheme of Arrangement, Amalgamation and Reconstruction under Section 391 to 394 of the Companies Act, 1956 between the Company, RFCL Limited and Alved Pharma and Foods Private Limited, the entire Vetnex Division of RFCL Limited was de-merged and was transferred and vested in the Company and Alved Pharma and Foods Private Limited was amalgamated with the Company with effect from 1 April 2008.
Zoetis Pharmaceutical Research Private Limited acquired entire share capital of the Company from RFCL Limited and other shareholders vide share purchase agreement dated 3 June 2009 and consequently the Company became its wholly owned subsidiary. The name of the Company was changed to Pfizer Animal Health India Limited with effect from 20 July 2010 and fresh certificate of incorporation was obtained. The name of the Company was further changed on 23 April 2013 to Zoetis India Limited.
During the previous year, Pfizer Animal Pharma Private Limited ("PAPPL") ('a wholly owned subsidiary' of the Company) had beenamalgamated with the Company, pursuant to the approval of Board of Directors on 26 March 2014 and sanctioned by the Hon’ble High Court of Bombay on 5 December 2014 which was filed with the Registrar of Companies on 2 January 2015. PAPPL, incorporated with the main object to acquire the animal health business from Pfizer Limited pursuant to the business spin-offs undertaken globally by the parent entities of both the companies in 2012, was amalgamated with the Company pursuant to the Scheme of Amlagamation (hereinafter referred to as 'the Scheme'), as on and from 1 April 2012, being the appointed date.
The Company is engaged in trading and manufacturing of animal feeds and supplements.
UNSECURED LOANS:
(INR
In Million)
|
Particulars |
As
on 31.03.2016 |
As
on 31.03.2015 |
|
SHORT TERM
BORROWING |
|
|
|
Intercorporate borrowings |
2526.400 |
2526.400 |
|
Total |
2526.400 |
2526.400 |
INDEX OF CHARGE:
|
SNO |
SRN |
CHARGE ID |
CHARGE HOLDER NAME |
DATE OF CREATION |
DATE OF MODIFICATION |
DATE OF SATISFACTION |
AMOUNT |
ADDRESS |
|
1 |
A94083862 |
10177266 |
YES BANK LIMITED |
06/08/2009 |
- |
18/08/2010 |
175100000.0 |
9TH FLOOR, NEHRU CENTRE, DISCOVERY OF INDIA,DR. ANNIE BESANT ROAD, WORLI,MUMBAIMH400018IN |
|
2 |
A79312930 |
10173980 |
STATE BANK OF INDIA (MID CORPORATE LOAN ADMINISTRATIVE UNIT) |
17/08/2009 |
- |
29/01/2010 |
333300000.0 |
2ND FLOORCHANDNI CHOWKDELHIDL110006IN |
|
3 |
A79315313 |
10176455 |
ICICI BANK LIMITED |
28/08/2009 |
- |
29/01/2010 |
70000000.0 |
LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN |
|
4 |
A68132174 |
80016375 |
INDIAN OVERSEAS BANK |
26/09/2003 |
27/10/2007 |
12/08/2009 |
46320000.0 |
K.K NAGAR BRANCH267, LAKSHMANASWAMY SALAICHENNAITN600078IN |
|
5 |
A68131069 |
80016376 |
INDIAN OVERSEAS BANK |
26/09/2003 |
- |
12/08/2009 |
19000000.0 |
P S B B BRANCH, K K NAGARCHENNAITN600078IN |
FIXED ASSETS:
Tangible assets
- Land
- Buildings
- Plant and equipment
- Furniture and fixtures
- Vehicles
- Office equipment
- Computer equipments
- Leasehold improvements
Intangible assets
- Goodwill
- Brands and trade marks
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 64.16 |
|
|
1 |
INR 85.84 |
|
Euro |
1 |
INR 76.23 |
INFORMATION DETAILS
|
Information
Gathered by : |
SHW |
|
|
|
|
Analysis Done by
: |
PSD |
|
|
|
|
Report Prepared
by : |
KVT |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low risk
of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably on
secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the business
is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.